Technology | 2017.07.05
ProMIS Neurosciences to Present Preclinical Data from Alzheimer's Disease Program at AAIC 2017
ALZHEIMER\'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC): 16-20 JULY, 2017 LONDON, ENGLAND
Chief Development Officer Dr. Johanne Kaplan to chair session
TSX: PMN
TORONTO and CAMBRIDGE, MA, July 5, 2017 /PRNewswire/ - ProMIS Neurosciences, Inc., a biotechnology company focused...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]am-at-aaic-2017-632633383.html
